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Abstract
Preterm birth is the leading cause of infant death worldwide, but the
causes of preterm birth are largely unknown. During the early COVID19 lockdowns, dramatic reductions in preterm birth were reported;
however, these trends may be offset by increases in stillbirth rates. It
is important to study these trends globally as the pandemic continues,
and to understand the underlying cause(s). Lockdowns have
dramatically impacted maternal workload, access to healthcare,
hygiene practices, and air pollution - all of which could impact
perinatal outcomes and might affect pregnant women differently in
different regions of the world.
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In the international Perinatal Outcomes in the Pandemic (iPOP) Study,
we will seize the unique opportunity offered by the COVID-19
pandemic to answer urgent questions about perinatal health. In the
first two study phases, we will use population-based aggregate data
and standardized outcome definitions to: 1) Determine rates of
preterm birth, low birth weight, and stillbirth and describe changes
during lockdowns; and assess if these changes are consistent globally,
or differ by region and income setting, 2) Determine if the magnitude
of changes in adverse perinatal outcomes during lockdown are
modified by regional differences in COVID-19 infection rates,
lockdown stringency, adherence to lockdown measures, air quality, or
other social and economic markers, obtained from publicly available
datasets. We will undertake an interrupted time series analysis
covering births from January 2015 through July 2020.
The iPOP Study will involve at least 121 researchers in 37 countries,
including obstetricians, neonatologists, epidemiologists, public health
researchers, environmental scientists, and policymakers. We will
leverage the most disruptive and widespread “natural experiment” of
our lifetime to make rapid discoveries about preterm birth. Whether
the COVID-19 pandemic is worsening or unexpectedly improving
perinatal outcomes, our research will provide critical new information
to shape prenatal care strategies throughout (and well beyond) the
pandemic.
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Introduction

The COVID-19 pandemic and response measures taken to
mitigate the spread of infection have dramatically impacted
health and health systems across the globe. Maternal and child
health is at high risk, especially in low- and middle-income
countries where resources for health care are already limited1.
Pandemic response measures may have profound societal
impacts owing to the combination of constrained supply, reduced
resources, suppressed human interaction, and worsening
socio-economic inequality. Projections already suggest about
a 45% increase in child deaths and 39% increase in maternal
deaths across low- and middle-income countries related to
the pandemic2.
Unexpectedly, recent evidence from some high-income
countries suggests unprecedented reductions in preterm
births (up to 90% in Denmark and 23% in the Netherlands)
and births classified as very low birth weight (70% in Ireland)
following the COVID-19 lockdowns3–5. At the same time,
reports from Nepal and India show an alarming increase in
stillbirths and preterm births related to changes in maternity
care6,7. Increases in stillbirth have also been seen in the UK
and Italy (Lazio region)8,9. In California, preterm birth rates
seem largely unchanged during the pandemic period, except
for a modest increase (11%) in very preterm birth, driven
primarily by the Hispanic/Latinx population10.
It is critical to evaluate these seemingly contrasting trends
and to understand the underlying mechanisms. The pandemic
mitigation measures have substantially impacted maternal
workload11, access to healthcare12, hygiene practices13, air
pollution14, nutrition15–17, and non-SARS-CoV-2 infection18,
each of which may have affected maternal and perinatal
outcomes disproportionately in different socio-economic and
regional settings. It is plausible that changes in exposures to
inflammatory triggers, such as infections19–21 and air pollution22,
may be partly responsible for changes to some perinatal outcomes, such as spontaneous preterm birth. We will therefore
seize the unique opportunity resulting from the global
COVID-19 pandemic to answer pressing questions on pandemic
lockdowns and perinatal health on a global scale.
To address the impact of the pandemic response measures
on perinatal health, the international Perinatal Outcomes in the
Pandemic (iPOP) study, is working in partnership with the
International COVID-19 Data Alliance (ICODA, supported
by the COVID-19 Therapeutics Accelerator) to establish an
inclusive international research programme that will collaborate
to focus on key questions relevant to countries across the globe
of all income levels. The initial focus of iPOP will be on the
impact of COVID‐19 pandemic lockdowns on perinatal outcomes,
including preterm birth, low birth weight, and stillbirth.

Objective
The overall objective of iPOP is to determine the impact of
pandemic lockdowns on perinatal outcomes worldwide, and to
investigate potential mechanisms underlying these effects.

Protocol
Study goals and conceptual framework

The overarching goal of iPOP is to:
• Investigate the impact of COVID-19 lockdowns on
perinatal outcomes (including preterm birth, low birth weight,
and stillbirth);
• C
 ompare the impact of COVID-19 lockdown on perinatal
outcomes by country income setting: low-income countries (LICs), lower-middle-income countries (LMICs),
upper-middle-income countries (UMICs) and high-income
countries (HICs);
• E
 xplore the underlying societal and etiological factors
that are associated with between-country differences in
the impact of COVID-19 lockdown on perinatal outcomes.
The conceptual framework (Figure 1) for the iPOP project
is intended to help build a series of work packages (WPs),
each increasing in complexity and building on the previous
findings. Within this protocol we address WP1 and WP2.
WP1 - Describe global trends and regional differences in adverse
perinatal outcomes during COVID-19 pandemic lockdowns, using
population-based aggregate data and standardized outcome
definitions: Report rates of preterm birth, low birth weight, and
stillbirth and describe changes during the pandemic lockdown.
Determine if these changes are consistent globally, or if they
differ between or within LIC, LMIC, UMIC and HIC settings.
WP2 - Address contextual influences and mechanisms for
changes in preterm birth, stillbirth, and low birth weight during
the COVID-19 pandemic, using population-based aggregate and
publicly available data: determine if the magnitude of regional
changes in adverse perinatal outcomes during lockdown are
potentially modified by regional differences in COVID-19
infection rates, lockdown stringency, adherence to lockdown
measures, air quality, and other social and economic markers
available from public datasets.
Possible mechanisms driving the association between pandemic
lockdown measures and perinatal outcomes are represented
in a directed acyclic graph (DAG) in Figure 2.

Aims
In WP1, we will estimate the impact of pandemic lockdowns
on global incidence of preterm birth, low birth weight, and
stillbirth using population-based data. Specifically, we will
answer the following questions:
1. Has implementation of COVID-19 pandemic lockdowns
been associated with a change in preterm birth rate (<37 weeks
gestation)?
2. Does the association vary:
a) When the outcome is restricted to spontaneous preterm
birth (preterm birth preceded by spontaneous contractions
and/or preterm prelabour rupture of membranes)?
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Figure 1. iPOP Study Conceptual Framework. OECD, Organisation for Economic Co-operation and Development.

Figure 2. Full directed acyclic graph (DAG) of lockdown to perinatal outcomes.
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b) W
 hen the outcome is restricted to early preterm birth
(<32 weeks gestation)?
3. Does any association with preterm birth remain when
analyses are restricted to live births only (i.e. exclusion of
stillbirths)?
4. Has implementation of COVID-19 pandemic lockdown
been associated with a change in low birth weight rate (<2500g)?
5. Has implementation of COVID-19 pandemic lockdown been
associated with a change in stillbirth rate?
6. Has implementation of COVID-19 pandemic lockdown
been associated with a change in post term birth rate (≥42 weeks
gestation)?
7. Do any observed associations with preterm birth, low birth
weight, and stillbirth vary by country income setting (LIC,
LMIC, UMIC, HIC)?
Our primary hypothesis is that the rate of spontaneous
preterm birth, low birth weight and/or stillbirth is changed
during pandemic lockdowns worldwide. Our secondary hypothesis is that the magnitude and/or direction of the change in the
spontaneous preterm birth, low birth weight, and/or stillbirth
varies by country income setting as classified by the World Bank
income grouping.
In WP2 we will build directly from WP1 with the addition
of national/regional characteristics derived from publicly
available datasets to explore the influence of the association
between lockdown measures and adverse perinatal outcomes.
Specifically, we will address the following questions:
8. Are the direction and magnitude of any changes in preterm
birth, low birth weight and/or stillbirth rates observed in WP1
modified by factors such as:
a.	Lockdown stringency index (see section Exposures
below)
b.	Adherence to lockdown indicated by traffic and social
mobility data
c.	Ambient air quality
d.	COVID-19 rates
e.	Parental leave policy
f.	Socioeconomic setting
g.	Gross domestic product
h.	World region (East Asia and Pacific, Europe and
Central Asia, Latin America & the Caribbean, Middle
East and North Africa, North America, South Asia,
Sub-Saharan Africa).

General approach
We will analyse aggregate population-based data provided by
collaborators from different national/regional sites. Our primary

method of analysis will be an interrupted time series analysis
(ITSA) and we will consider alternative quasi-experimental
approaches as appropriate.
Results from each contributing site will be meta-analysed,
if appropriate. We will classify data into one of three tiers
(Standard, Enhanced, or Investigative) based on the nature
of the datasets in terms of population coverage, quality and
completeness, and availability of required variables (Table 1).
Standard data meet the minimum criteria for inclusion in the
main analysis of at least one primary or secondary outcome.
Enhanced data meet the minimum criteria for inclusion in the
main analysis of a primary or secondary outcome, as well as
including additional data allowing inclusion in one or more
additional or sensitivity analyses. Investigative data do not meet
the minimum criteria to be included in the main analysis of a
primary or secondary outcome but can be included in supplementary analyses exploring trends (designed to promote wide
geographical coverage).
A single contributing dataset may be categorised in different
tiers for different analyses, e.g. a dataset with low completeness on gestational age but high completeness on birth weight
might be categorised as investigative for analyses of preterm birth
and as enhanced for analyses of low birth weight.
Wherever possible we have aligned our definitions with those
of the World Health Organization (WHO)23. To allow meaningful comparison of international data, in our main analyses
definitions we have used a gestational age threshold of 28 weeks,
and birth weight threshold or 1000g for inclusion (identified
by the extension “_m”). This is in recognition that inclusion
of extreme preterm and extremely low birthweight births can
disrupt the validity of such comparisons. However, these births
will be included in definitions for the enhanced analyses (identified
by the extension “_e”).
We have chosen to use a denominator of total births for our
primary outcome of preterm birth. Figure 3 shows a simplified
DAG justifying use of this denominator. COVID-19 infection
might increase susceptibility to intrapartum stillbirth, whereas
lockdown might reduce susceptibility to intrapartum stillbirth (because of fewer infections/ less pollution) or increase
it (due to changes in access to maternity care). Intrapartum
stillbirth here is a collider so we should not condition on intrapartum stillbirth. As it is difficult to get good information on
whether stillbirths are intrapartum (as opposed to antenatal),
total birth is appropriate as the denominator.

Methods
Study population

Our aim is to capture, at a minimum, data on all births (live
and stillbirth) from 28+0 to 44+6 weeks gestation inclusive; or
above ≥1000g birth weight. We also aim to capture additional
data on all births (live and stillbirth) from 22+0 to 27+6 weeks
gestation, or between 500g and 999g. These data will be
included in enhanced analyses.
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Table 1. Characteristics of datasets included in the iPOP Study.
Coverage
Standard dataset

National, subnational, population-based data

Enhanced dataset

National, subnational, population-based data

Investigative dataset

Institutional level data or other non-population-based data

Completeness
Standard dataset

≥90% births with a meaningful/feasible value for an outcome

Enhanced dataset

≥90% births with a meaningful/feasible value for an outcome

Investigative dataset

<90% births with a meaningful/feasible value for an outcome

Time period
Standard dataset

1 Jan 2015 to 31 July 2020

Enhanced dataset

1 Jan 2015 to most recent data available

Investigative dataset

1 Jan 2018 to 31 July 2020

Breakdown of data
Standard dataset

By consecutive calendar month

Enhanced dataset

By consecutive calendar month + by consecutive International
Standard (ISO) week and

Investigative dataset

By any other time frame or discontinuous data

Birth categories
Standard dataset

All births
All births +/-

Enhanced dataset

Live births and stillbirths +/Spontaneous preterm births
Live births only, population-based data /

Investigative dataset

All births, institutional level data or other non-population-based
data

Gestation
Standard dataset

28+0 - 36+6 weeks
≥37+0 weeks
22+0 - 27+6 weeks
28+0 - 31+6 weeks

Enhanced dataset

32+0 - 36+6 weeks
37+0 - 41+6 weeks
≥42+0 weeks

Investigative dataset

Preterm birth identified by checkbox (without registration of
gestational age)

Birth weight
Standard dataset

1000 – 2499g
≥2500g
500 – 999g (if available)

Enhanced dataset

1000 – 1499g
1500 – 2499g
≥2500g

Investigative dataset

Low birth weight identification by checkbox (without registration
of birth weight)
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Figure 3. Directed acyclic graph (DAG) - Simple version (work package 1).

Study period
The main analysis study period is January 1, 2015 to July 31,
2020, covering the first lockdown period (in 2020) and the
previous five calendar years. We will include data from
January 1, 2018 to July 31, 2020 in investigative analysis if
earlier data is not available. We will request the most recent
data available to allow enhanced analyses covering a wider
time period.
Exposures
The primary exposure will be a binary variable for lockdown
based on the stringency index. We will use the stringency
index from the Oxford COVID-19 Government Response Tracker.
The Oxford COVID-19 Government Response Tracker provides
a systematic cross-national, cross-temporal measure to understand how government responses have evolved over the full
period of the disease’s spread. It collects information on different
policies and interventions that governments have instituted in
response to the COVID-19 pandemic and using standardized
series of indicators creates a suite of composites indices to
measure the extent of these responses. The indicators cover
information on containment and closure policies (e.g. school
closures and restrictions in movement) (C1-C8); economic policies (e.g. income support to citizens or provision of foreign aid)
(E1-E4); and record health system policies (e.g. COVID-19
testing regimes or emergency investments into healthcare)
(H1-H5). The lockdown stringency index is calculated using
only the policy indicators C1-C8 and H1. The value of the
index on any given day is the average of nine sub-indices
pertaining to the individual policy indicators, each taking

a value between 0 and 100. If the most stringent policy is
only present in a limited area or region, a binary flag variable
denotes limited scope. The codebook for the stringency index is
publicly available.
We will define lockdown as a score of ≥50 on the Oxford
COVID-19 Government Response Tracker stringency index.
The decision on this arbitrary cut off has been influenced by
scoping of stringency index data in high income settings and
comparison of stringency indexes in settings which have and
have not implemented lockdown measures. For example, Sweden
(which has not had a ‘lockdown’) never implemented measures during the study period that added up to higher than 50 on
the stringency index, compared to neighbouring Denmark,
which scored above 50 throughout the study period in 2020.
We will record timing of reaching a score ≥50 separately for
each country/region. Our primary analysis will focus on the
start date of pandemic lockdown defined as the first date when a
country/region’s stringency exceeded 49 (i.e. as a stringency
score of ≥50).
Subsequent analyses may include the:
• Time period of pandemic lockdown: defined as a continuous
calendar period during which a country/region has a stringency
score of ≥50
• T
 otal duration of pandemic lockdown: defined as the
sum of all calendar periods during which a country/region
has a stringency score of ≥50
Note: The beginning and length of lockdown may vary by
country/region
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Comparator
Births during the 2020 lockdown periods will be compared with
births occurring before the first date when a country/region’s
stringency exceeded 49 (i.e. as a stringency score of ≥50),
defined by lockdown stringency index in each country/region.
The exact comparator time period may vary by country/region.
Outcomes
Primary outcome
• Preterm birth rate_m (main analysis: any birth 28+0- 36+6
weeks gestation; denominator total births ≥28+0 weeks).
• P
 reterm birth rate_e (enhanced analysis: any birth 22+0- 36+6
weeks gestation; denominator total births ≥22+0 weeks).
Secondary outcomes
• Early preterm birth rate_m (main analysis: any birth 28+0 31+6 weeks gestation; denominator total births ≥28+0 weeks).
• E
 arly preterm birth rate_e (enhanced analysis: any birth
22+0 - 31+6 weeks gestation; denominator total births ≥22+0
weeks).
• E
 xtreme preterm birth rate_e (enhanced analysis: any birth
22+0 - 27+6 weeks gestation; denominator total births ≥22+0
weeks).
• S
 pontaneous preterm birth rate_e (enhanced analysis: any
birth 28+0- 36+6 weeks gestation which is preceded by spontaneous contractions or preterm prelabour rupture of membranes
[PPROM]; denominator total births ≥28+0 weeks).
• S
 pontaneous preterm birth rate_e (enhanced analysis: any
birth 22+0- 36+6 weeks gestation which is preceded by spontaneous contractions or preterm prelabour rupture of membranes
[PPROM]; denominator total births ≥22+0 weeks).
• P
 ost term birth rate_m (main analysis: any birth ≥42+0
weeks gestation; denominator total births ≥28+0 weeks).
• S
 tillbirth rate_m (main analysis: any stillbirth ≥28+0
weeks gestation (or ≥1000g if gestation not available);
denominator total births ≥28+0 weeks (or ≥1000g if gestation
not available).
• S
 tillbirth rate_e (enhanced analysis: any stillbirth ≥22+0
weeks gestation (or ≥500g if gestation not available); denominator total births ≥22+0 weeks (or ≥500g if gestation not
available).
• L
 ow birth weight rate_m (main analysis: any birth 1000–2500g;
denominator live births ≥1000g).

Potential confounders/effect modifiers
Potential confounders/effect modifiers for the entire iPOP study
are represented in a DAG (Figure 2). We recognise that i) many
of the variables in the DAG (e.g. maternal age distribution) are
unlikely to have significantly changed within the timeframe
of the analysis and thus unlikely to be confounders, and ii) our
initial analysis strategy is to compare changes in association
with lockdown within datasets; thus these variables are less
relevant. To allow expedient provision and analysis of data
we propose using aggregate data for WP1 and WP2; with
more complex analysis enabled with provision of individual
participant data and provider level data in subsequent WPs.
National/regional level societal characteristics that we are
interested in exploring include mediating and moderating factors obtained from publicly available datasets as described in the
section below. Country classification by income as defined
by the World Bank (LIC, LMIC, UMIC, HIC) as a proxy for
wider social security and healthcare system.

Data collection and characteristics of datasets
We have extended invitations for national, regional and
institutional data custodians of birth data to participate through
formal and informal networks, social media, lay and scientific media. Participating countries as of December 1st 2020 are
shown in Figure 4.
We will request aggregate data from each data provider
using an excel spreadsheet template, which includes details
on levels of missing data. We will classify data provided to
iPOP as Standard, Enhanced, or Investigative, based on the
characteristics described in Table 1.
We will also ask for completion of a questionnaire regarding
the source of data including, country of origin, region(s) covered and size of population covered. To assist data providers
on which template to use to capture their data, we have
constructed a data flow diagram (Figure 5).
For WP2 we will use the following publicly available data sources:
• L
 ockdown stringency: Using the stringency index (see section Exposures) and COVID-19: Containment and Health
Index defined as a continuous (0–100) or categorical
measures.
• S ocioeconomic status: Measured by Organisation for
Economic Co-operation and Development (OECD) better life
index.

• V
 ery low birth weight rate_e (enhanced analysis: any
birth 500 – 1500g; denominator live births ≥500g).

• A
 mbient air quality: Estimated using the Data Integration Model for Air Quality (DIMAQ)24, which uses input
data from a variety of public sources including: Open Air
Quality, NASA Modern-Era Retrospective analysis for Research
and Applications version 2 (MERRA-2) global modelling
initiative, satellite imagery data from the Multiangle Implementation of Atmospheric Correction (MAIAC), and global
population density from the NASA/Columbia University
Socioeconomic Data and Applications Center.

• E
 xtremely low birth weight rate_e (enhanced analysis:
any birth 500g – 1000g; denominator live births ≥500g).

• A
 dherence to lockdown indicated by traffic and movement
trends: Obtained from publicly available Google mobility data.

• L
 ow birth weight rate_e (enhanced analysis: any birth
500–2500g; denominator live births ≥500g).
• V
 ery low birth weight rate_m (main analysis: any birth
1000 – 1500g; denominator live births ≥1000g).
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Figure 4. Map of iPOP collaborating countries as of Dec 1, 2020.

Figure 5. Data request flow diagram.

• C
 OVID-19 rates: Nationally available via John Hopkins
COVID-19 infection rates
• P
 arental leave policy: Measured by World Bank Data
(yes/no; length of paid maternity leave).
• O
 ther country-level characteristics: Measured by World
Bank Data (including variables such as world region, GDP,

income expenditure, hospital beds, maternal education), The
Global Gender Gap Index, The Global Hunger Index and
Political stability index.

Data storage and analysis platform
We will use the Secure Anonymised Information Linkage (SAIL)
Databank, Swansea Wales, to store all data provided to iPOP.
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Upon completion of a Data Contribution Agreement between
each iPOP data provider and the SAIL Databank, each data
providers will either:
i)	upload aggregated data directly to the SAIL central
repository, or
ii)	transfer their data to the University of Edinburgh
(RM), who will upload these to SAIL on their behalf.
Data will be transferred into SAIL using the “Split-file” process with the support of the Informatics Service, National Health
Services (NHS) of Wales. Person-level demographics are
translated to an Anonymous Linking Field (ALF). Additional
information on the SAIL File Structure & Data Transfer
processes can be found here.
iPOP Team Members (analysis team) will access data stored
within SAIL via a remote access and conduct data analyses
remotely on the International COVID-19 Data Alliance (ICODA)
Workbench, via a federated approach. ICODA is a new data
platform that allows scientists and researchers across the globe
to discover, access and analyse multi-dimensional datasets in a
confidential and secure environment. More information can be
found on the HDR UK website.
To ensure outputs are confidential and safe, all statistical
outputs will be checked using Statistical Disclosure Control
(SDC) procedures before being exported out of the virtual
environment. We will use SDC guiding principles from the
Handbook on SDC for Outputs by the UK Data Service. This
will prevent the identity of a birth from being revealed or inferred
from outputs.
A catalogue on the data variables captured will be recorded
alongside relevant metadata. These high-level summaries will
be made publicly available.

Data analysis
All analyses will be fully specified in a comprehensive
Statistical Analysis Plan. We will adhere to relevant reporting
guidance for example the Strengthening the Reporting of
Observational studies in Epidemiology (STROBE).
Descriptive analysis
We will use summary statistics and data visualisations to
describe, explore and compare the national/regional data to
describe the study outcomes and other perinatal characteristics,
including:
• All births

In WP2 we will use summary statistics and data visualisations
(e.g. choropleth maps) to describe, explore and compare the
national/regional data.
Statistical modelling
We will undertake population-based ITSA for main analyses
of primary and secondary outcomes. We will use time-series
techniques to capture any underlying temporal trends and
seasonality in the data before the implementation of lockdown
measures. We will consider both linear and more flexible trends.
We will use these time-series regression models to forecast (or
predict) the expected trends and will compare these to the
observed trends seen after the lockdown measures. This will capture both immediate (i.e. step) changes and gradual (i.e. slope)
changes in the outcome in relation to implementation of lockdown
measures in our models. All analyses will be prespecified in a
Statistical Analyses Plan before analysis.
Meta-analysis
We will undertake a meta-analysis of national/regional results,
on the step-change and the difference between the forecast and observed outcomes at different time points after the
implementation of lockdown measures. We will also stratify
by country income setting as a dichotomous variable (LIC+LMIC
vs UMIC+HIC), since existing data suggests differing effects
in these groups. Statistical heterogeneity will be assessed using
I2 test.
For WP2, we will use these pooled estimates from WP1 in
meta-regression analyses. These will incorporate the moderator/
mediator variables as potential mechanisms at a national/regional
level. This will measure the influence of these mechanisms on
the association between lockdown measures and adverse perinatal
outcomes.
Sensitivity analyses
Where enhanced datasets are available for an outcome, we will
perform similar modelling techniques to those described above
with these enhanced data as sensitivity analyses to test the
robustness of the main analyses in different populations. These
analyses will be specified further in a comprehensive Statistical
Analysis Plan. Predefined examples include:
• Sensitivity analyses restricting the denominator for
our main outcomes of interest (excluding outcomes on
spontaneous preterm birth) from all births to only live births.
These analyses will be informative for the appropriateness of using datasets which only include information on live
births.

• Low birth weight

• S
 ensitivity analyses with varying cut-off points for our
lockdown definition (i.e. above and below 50) from the
stringency index to test the robustness of assigning
≥50 as the primary cut-off point. These analyses will also
allow inclusion of countries with less strict lockdown
measures, such as Sweden, and inform whether/to what extent
the observed associations might vary by lockdown stringency.

• Spontaneous preterm births

We will conduct supplementary analyses in investigative datasets.

• Live and stillbirths
• Preterm and post term births
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Output confidentiality
All outputs will be checked for any potential disclosure and
confidentiality breaches, using guidance from the Handbook on
SDC for Outputs by the UK Data Service.

Public and patient involvement
Public and patient involvement early in study design and
development ensures research studies are responsive to input,
guidance and advice, and can help identify and mitigate potential challenges early in the research process25. Further, public and
patient involvement helps to identify research outcomes that are
meaningful and pragmatic to knowledge users.
The iPOP team has engaged parents as patient partners early
in the study design and have built a working group to capture
and integrate patient involvement in the iPOP study as it moves
forward. Meeting monthly, patient partners will be involved
in developing effective and meaningful knowledge translation
and communication strategies for disseminating iPOP findings. Specific to WP2, patient partners will work with researchers to examine mechanistic effects of the pandemic lockdown
on perinatal outcomes. Patient partners will also work with
researchers to develop knowledge translation strategies to
ensure effective and meaningful dissemination of findings to
knowledge users.

Ethical considerations
To ensure transparent, equitable, and meaningful engagement,
we have developed Guiding Principles that outline the terms of
agreement for study leads and collaborators who are involved
in the iPOP Study. Each member of the iPOP Study must read
and sign the guiding principles document in order to collaborate
on the study. While not legally binding, this document provides
guidance and parameters around authorship, roles and
responsibilities, research integrity, communication and Team
Science guidelines.
The iPOP Study ensures confidentiality and security of the
processing of data for electronic files. Data will be safeguarded
by an appropriate level of security, technical and organisational
measures to prevent unauthorized disclosure or access, accidental or unlawful destruction, accidental loss or alteration, and
unlawful forms of processing. WP1 and WP2 will be based on
de-identified aggregate data only.
It will be assumed that any Team member sharing data within
the iPOP Study does so in accordance with relevant and
applicable legal and regulatory standards and obligations including but not limited to, confidentiality, data protection and
intellectual property, and access governance agreements. iPOP
collaborators must adhere to these policies and processes.
All collaborators must respect the iPOP principles of data
protection and processing, which include the following:

All contributed to iPOP data must be
• Processed fairly and lawfully
• Collected for specified and legitimate purposes
• A
 dequate, relevant and not excessive in relation to the
purpose
• Accurate
• Absent of personal identifiers (names, addresses, etc.)
• Stored not longer than necessary
• P
 rocessed under the responsibility and liability of the
data Controller for the provided data set
• H
 andled according to the EU GDPR rules (when hosted
in the UK)

Conclusions

Spanning 37 countries (Figure 4), the iPOP Study brings
together expertise in perinatology, epidemiology, environmental science, intersectional feminism, and data science within a
collaborative, equitable and interdisciplinary framework.
The iPOP Study will leverage the natural experiment arising
from the COVID-19 pandemic, to understand possible mechanisms of adverse perinatal outcomes and inform interventions and
policy. Further, iPOP will investigate the effects of pandemic
lockdowns by country income setting, incorporating data from
LICs to HICs across the globe on key perinatal outcomes.
The initial focus of iPOP will be on the impact of COVID-19
pandemic lockdowns on perinatal outcomes, including preterm birth, low birth weight, and stillbirth. Determining the
worldwide extent of changes in perinatal outcomes during the
COVID-19 pandemic will advance current understanding of
preventable causes of these pervasive perinatal outcomes.
Building on the first two phases of the iPOP Study described
in this protocol, iPOP further aims to investigate mechanisms
for any observed changes in perinatal outcomes during the
COVID-19 pandemic, using individual-level and setting-specific
data. In the next study phase (WP3), we aim to examine the
impact of maternal comorbidities (e.g. pregnancy complications; pre-existing chronic conditions including mental health),
COVID-19 and non-COVID-19 infections, socio-economic
factors, prenatal care, and birth practices on any associations
between pandemic lockdowns and perinatal outcomes.
Results of the iPOP Study will be rapidly translated through
our network of local and international stakeholders to inform
further research and testable interventions for improving
perinatal healthcare and social support systems during (and well
beyond) the COVID-19 pandemic.

Data availability

No data are associated with this article.
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This paper describes an important and ambitious global study investigating how the COVID
pandemic and lockdowns may have affected rates of preterm birth, stillbirth and low birth weight.
The vast multidisciplinary team of 121 researchers in 37 countries have come together to examine
variations in COVID-19 rates and lockdown stringency, as well as other factors such as pollution
levels, social deprivation and access to maternity care. Findings from the study may lead to a
deeper understanding of these factors and what might be done to improve care and outcomes in
the future.
The team’s hypothesis is that the rate of spontaneous preterm birth, low birth weight and/or
stillbirth is changed during lockdowns, and that the magnitude and/or direction of change varies
between low, low-middle, upper-middle and high income countries.
The research aims and questions are spelt out clearly and there is detailed explanation of how
each dataset will be managed. The figures make a complex protocol easier to understand.
The authors acknowledge some significant challenges, including the gathering of unreliable and
incomplete data and propose methods to account for this, along with the use of internationally
recognised definitions. I am not, however, completely convinced it will be possible to unpick
spontaneous preterm birth from all preterm births, as I know how unreliable the UK data relating
to this can be.
This is an important and very interesting project; I wish the team all the best and look forward to
reading the findings.
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Thank you for the opportunity to review this study protocol. The investigators propose a 5-year
multi-country study to assess the impact of the COVID-19 pandemic on perinatal outcomes,
including rates of preterm birth, low birth weight, and stillbirths, using an interrupted time series
analysis approach. The study design is appropriate for the described research questions, and the
investigators clearly articulate their intended methodological approach. It may be difficult to
assess the impact of the implementation of COVID-19 related lockdowns versus the impact of the
pandemic (and infection in pregnancy) itself. I agree with the investigators’ decision to focus on
gestational age 28+ weeks given the heterogeneity of international data and approaches to
classifying viability; the impact of the pandemic/lockdowns on earlier gestational ages will be
assessed in a separate analysis (enhanced analysis as described). Classifying stillbirth may be
challenging, given the differences in definitions and reporting internationally.
Minor additional comments:
Please standardize use of either “health care” or “healthcare” – both terms are currently
used in the manuscript.
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Last paragraph of introduction (page 5): Please delete comma after “study” in line 3 of the
paragraph.
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Last paragraph of introduction (page 5): Please change “COVID 19” to “COVID-19” in second
to last line of the paragraph.
Figure 1 (page 6): Change “birthweight” to “birth weight” to match remainder of manuscript.
Figure 2 (page 6): Change “birthweight” to “birth weight” to match remainder of manuscript.
Font size is quite small, making DAG difficult to read. If possible, resize figure to fit width of
page and increase font size. Current DAG only lists limited number of confounders, though
many more could be explored.
Figure 3 (page 3): Stillbirths are by definition always antenatal – consider using
“antepartum” to distinguish from “intrapartum” instead. Strict classification of ante- versus
intrapartum stillbirth may be difficult, depending on data sources.
Outcomes (page 10): Current birth weight categories and numerators/denominators do not
quite make sense. Would follow standard WHO or VON categories for defining and
calculating these. What about neonates with birth weight less than 500g? Growth-restricted
neonates may weigh less than 500 grams but still survive.
Figure 5: Change “birthweight” to “birth weight” to match remainder of manuscript.
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